Thyroid cancer trials in Netherlands

In Netherlands 8 Also abroad 226

8 trials · From ClinicalTrials.gov and EU CTIS (euclinicaltrials.eu), checked 12 November 2026. Ask the study team whether a trial fits you.

Phase 1Taking people
Drug Repurposing in Thyroid Carcinoma: a Feasibility Trial
Where
Nijmegen
Age
18 years and over
People
10
Run by
Radboud University Medical Center
See details and how to joinNCT07485569 · EU 2023-507214-28-00
Phase 2Taking people
A Study to Assess the Efficacy and Safety of FORE8394 in Participants With Cancer Harboring BRAF Alterations
Where
Rotterdam
Age
8 years and over
People
254 worldwide
Run by
Fore Biotherapeutics
See details and how to joinNCT05503797 · EU 2024-513578-23-00
Phase 1/2Taking people
A Study of Repotrectinib (TPX-0005) in Patients With Advanced Solid Tumors Harboring ALK, ROS1, or NTRK1-3 Rearrangements
Where
Amsterdam, Groningen
Age
12 years and over
People
500 worldwide
Run by
Turning Point Therapeutics, Inc.
See details and how to joinNCT03093116 · EU 2024-512606-25-00
No phaseNot yet taking people in Netherlands
Thyroid Hormone Replacement After Radio Iodine: Value and Efficacy
Where
Groningen, Nijmegen
Age
18 years to 75 years
People
40
Run by
University Medical Center Groningen
See details and how to joinNCT06647602 · EU 2024-511668-10-00
No phaseTaking people
Iodine Uptake After a Low Iodine Diet
Where
Groningen
Age
18 years to 75 years
People
25
Run by
University Medical Center Groningen
See details and how to joinNCT05599139
Phase 2Taking people
[18F]Tetrafluoroborate PET/CT for the Detection of Differentiated Thyroid Cancer: A Phase II Imaging Study
Where
Rotterdam, Utrecht
Age
18 years and over
People
40
Run by
Erasmus Universitair Medisch Centrum Rotterdam (Erasmus MC)
See details and how to join2024-516025-30-00 · EU 2024-516025-30-00
Phase 2Taking people
NEOAC
Where
Leiden
Age
18 years and over
People
20
Run by
Leids Universitair Medisch Centrum (LUMC)
See details and how to join2024-516126-54-00 · EU 2024-516126-54-00
Phase 2Taking people
NEO- and Adjuvant Targeted Therapy in Braf-mutated Anaplastic Cancer of the Thyroid (NEO-ATACT Study)
Where
Leiden
Age
18 years and over
People
20
Run by
Leiden University Medical Center
See details and how to joinNCT06079333